Flu News and Research

RSS

Australian Government must take the lead in tackling antibiotic resistance: NPS Board Chair Dr Janette Randall address to the National Press Club

NPS Board Chair Dr Janette Randall today called on the government to take the lead on a cross sectoral approach towards tackling the antibiotic-resistance crisis facing the Australian community.

26 Apr 2012

Dutch government rule export permit required to publish controversial bird flu study

Ron Fouchier of Erasmus Medical Center, "[t]he Dutch scientist at the center of the controversy over recent bird flu experiments, says that his team applied for government permission today to submit a paper describing their research to a science journal," NPR's health blog "Shots" reports.

26 Apr 2012

Text-message intervention may help boost flu vaccination rates in children

Text message reminders to parents about flu vaccinations may help boost the number of children vaccinated, according to researchers at Columbia University Medical Center and NewYork-Presbyterian Hospital. Full study findings are reported in the April 25 issue of the Journal of the American Medical Association.

26 Apr 2012

Rep. Sensenbrenner sends second letter inquiring about U.S. government's review of controversial H5N1 studies

"A senior Republican in the U.S. House of Representatives is asking more questions about how the U.S. government reviewed two controversial H5N1 avian influenza studies, and how it wrote a new policy for reviewing taxpayer-funded studies that might be used for good and evil," ScienceInsider reports.

25 Apr 2012

Text messaging increases flu vaccination coverage in low-income children

A text messaging intervention with education-related messages sent to parents increased influenza vaccination coverage compared with usual care in a traditionally hard-to-reach, low-income, urban, minority population of children and adolescents, although coverage overall remained low, according to a study in the April 25 issue of JAMA.

24 Apr 2012

Process of reviewing controversial experiments for publication must be streamlined in future

"We can worry less that a newly created bird flu virus might kill tens or hundreds of millions of people if it escaped from the laboratory," a New York Times editorial states. "But there is still some residual danger. And we remain appalled at the slipshod way in which this research was authorized despite its potential dangers to public health and national security," the editorial continues.

24 Apr 2012

U.S. gives go-ahead on publication of H5N1 research; Dutch regulators continue to debate

The U.S. government on Friday formally accepted a recommendation from the National Science Advisory Board for Biosecurity (NSABB) "to publish two controversial studies of the H5N1 avian influenza virus, moving the pair of papers another step closer to publication," ScienceInsider reports.

24 Apr 2012

Women & Infants named lead center in 14-site study of cytomegalovirus

Women & Infants Hospital of Rhode Island, through its participation in the Maternal-Fetal Medicine Units Network, has been named the lead center in a 14-site, $25 million study of cytomegalovirus (CMV), the most common infection during pregnancy.

24 Apr 2012

Health Management first quarter net revenue increases 18.4% to $1.485B

Health Management Associates, Inc. today announced its consolidated financial results for the first quarter ended March 31, 2012.

24 Apr 2012

New drug can prevent exacerbations of asthma due to common cold: Trial report

For the tens of thousands of asthma sufferers in the UK there is a “breakthrough” drug that reduces complications caused by the common cold, it is claimed.

22 Apr 2012

New data shows consolidation of interferon-free revolution in HCV treatment

New data presented at the International Liver Congress 2012 shows consolidation of the interferon-free (IFN) revolution in HCV treatment. The much anticipated data from a number of clinical trials confirm that combinations of antivirals offer the hope of shorter, more effective treatment with fewer side effects.

20 Apr 2012

NSABB calls for global guidelines for conducting, communicating research involving dangerous pathogens

NewScientist reports on the U.S. National Science Advisory Board for Biosecurity's (NSABB) recommendation that revised versions of two controversial studies on H5N1 avian flu be published in scientific journals, reversing its previous recommendation that the studies only be published if certain details were withheld. According to the news service, dissent among the board members over the issue has prompted the committee to "propose talks to draft global guidelines for doing and communicating work involving dangerous pathogens."

20 Apr 2012

Interferon beta-1a shows promise against MS

People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.

20 Apr 2012

Positive data from Synairgen’s SNG001 Phase II trial on asthma

Scientists from the University of Southampton and Synairgen, a respiratory drug development company spun out from the University, can announce positive data from its Phase II clinical trial, into the effectiveness of the drug SNG001 (inhaled interferon beta) for asthma patients.

20 Apr 2012

White House science adviser responds to inquiry regarding handling of H5N1 research controversy

"White House science adviser John Holdren has replied to questions asked last month by Representative Jim Sensenbrenner (R-Wisc.) about how the Obama Administration has handled the controversy surrounding two studies that showed how to make the H5N1 avian influenza virus transmissible between mammals," ScienceInsider reports.

19 Apr 2012

1 in 5 Australians expect antibiotics for coughs and colds: New NPS campaign

The survey also revealed a plethora of misconceptions when it comes to antibiotics with only half of respondents knowing that bacteria are becoming resistant to antibiotics. Only 40% knew antibiotics should not be taken for viruses and many (40%) did not know that taking antibiotics when they’re not needed contributes to antibiotic resistance. More than half did not know resistance increases when you don’t complete the course as directed and in general, the youth audience had less knowledge.

18 Apr 2012

Flu outbreak at veterans home

State Veterans' Affairs Commissioner Linda Schwartz told The Associated Press that the veterans were taken to Hartford Hospital after a number began complaining of flu-like symptoms. The 18 men live at the Connecticut State Veterans Home in either the Sgt. John L. Levitow Veteran's Health Center or a residential facility.

17 Apr 2012

FDA grants 510(k) clearance for QIAGEN’s molecular detection PCR technology

QIAGEN N.V. today announced that the U.S. Food and Drug Administration (FDA) has granted two 510(k) clearances for its real-time PCR (polymerase chain reaction) instrument Rotor-Gene Q MDx and a compatible test for the detection of Influenza A/B, the artus Infl A/B RG RT-PCR Kit, for in vitro diagnostic use.

From QIAGEN Manchester Limited 17 Apr 2012

Flu shots offered to populations at risk at the beginning of season

All Care Inala Medical Centre doctor Michael Ho said flu shots were becoming more popular each year. “Flu seasons tends to begin in late March early April to June,” he said. “More and more people are opting to get vaccinations because they are promoted well within the community.” He added, “It is particularly important for elderly people to be immunized because their immune system is already not at its best…This is also the case for people who have chronic medical conditions like diabetes, severe asthma, or heart disease. With their current condition, if they catch the flu they can end up with a worse outcome.”

12 Apr 2012

Financial Times analysis examines efforts to address dual risk research

A Financial Times analysis examines how the international community is working "to ensure scientific work can proceed without falling prey to accidental leaks or malevolent intent," following controversy surrounding two studies on the H5N1 bird flu virus.

12 Apr 2012

Flu News and Research

Australian Government must take the lead in tackling antibiotic resistance: NPS Board Chair Dr Janette Randall address to the National Press Club

Dutch government rule export permit required to publish controversial bird flu study

Text-message intervention may help boost flu vaccination rates in children

Rep. Sensenbrenner sends second letter inquiring about U.S. government's review of controversial H5N1 studies

Text messaging increases flu vaccination coverage in low-income children

Process of reviewing controversial experiments for publication must be streamlined in future

U.S. gives go-ahead on publication of H5N1 research; Dutch regulators continue to debate

Women & Infants named lead center in 14-site study of cytomegalovirus

Health Management first quarter net revenue increases 18.4% to $1.485B

New drug can prevent exacerbations of asthma due to common cold: Trial report

New data shows consolidation of interferon-free revolution in HCV treatment

NSABB calls for global guidelines for conducting, communicating research involving dangerous pathogens

Interferon beta-1a shows promise against MS

Positive data from Synairgen’s SNG001 Phase II trial on asthma

White House science adviser responds to inquiry regarding handling of H5N1 research controversy

1 in 5 Australians expect antibiotics for coughs and colds: New NPS campaign

Flu outbreak at veterans home

FDA grants 510(k) clearance for QIAGEN’s molecular detection PCR technology

Flu shots offered to populations at risk at the beginning of season

Financial Times analysis examines efforts to address dual risk research

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News